TherapeuticsMD (TXMD) FCF Margin (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly FCF Margin came in at 130.39% in Q1 2026, down 4748.0% YoY from 2.81% in Q1 2025, and up 210.49% on a QoQ basis from 41.99% in Q4 2025.
TherapeuticsMD (TXMD) FCF Margin (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 16 years of FCF Margin data on file, last reported at 130.39% in Q1 2026.
- Quarterly FCF Margin fell 4748.0% year-over-year to 130.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 80.5% (down 3346.0% YoY) and the FY2025 annual result came in at 81.2%, up 1476.0% from the prior year.
- FCF Margin grew to 130.39% in Q1 2026, from 41.99% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 5004.52% in Q3 2022 to a low of 10013.21% in Q3 2023.
- A 5-year average of 985.8% and a median of 2.55% in 2024 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin plunged 1501773 bps — and 2024, when it soared 1000023 bps.
- Tracing TXMD's FCF Margin over 5 years: stood at 32.99% in 2022, then plunged by 4799 bps to 1550.32% in 2023, then surged by 100 bps to 2.55% in 2024, then soared by 1548 bps to 41.99% in 2025, then surged by 210 bps to 130.39% in 2026.
- The last three FCF Margin figures came in at 130.39% (Q1 2026), 41.99% (Q4 2025), and 127.42% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 89.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.64% |
| Mar 31, 2026 | 130.39% |
| Dec 31, 2025 | 41.99% |
| Sep 30, 2025 | 127.42% |
| Jun 30, 2025 | 40.02% |
| Mar 31, 2025 | 177.86% |
| Dec 31, 2024 | 2.55% |
| Sep 30, 2024 | -12.98% |
| Jun 30, 2024 | 620.94% |
| Mar 31, 2024 | -73.16% |
| Dec 31, 2023 | -1,550.32% |
| Sep 30, 2023 | -10,013.21% |
| Jun 30, 2023 | -665.68% |
| Mar 31, 2023 | -2,096.15% |
| Dec 31, 2022 | 32.99% |
| Sep 30, 2022 | 5,004.52% |
| Jun 30, 2022 | -5,948.28% |
| Mar 31, 2022 | -2,577.55% |
| Dec 31, 2021 | 257.00% |
| Sep 30, 2021 | -150.17% |